Luisa Castro-Laria

500 total citations
11 papers, 155 citations indexed

About

Luisa Castro-Laria is a scholar working on Genetics, Epidemiology and Surgery. According to data from OpenAlex, Luisa Castro-Laria has authored 11 papers receiving a total of 155 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Genetics, 6 papers in Epidemiology and 5 papers in Surgery. Recurrent topics in Luisa Castro-Laria's work include Inflammatory Bowel Disease (8 papers), Microscopic Colitis (5 papers) and Eosinophilic Esophagitis (2 papers). Luisa Castro-Laria is often cited by papers focused on Inflammatory Bowel Disease (8 papers), Microscopic Colitis (5 papers) and Eosinophilic Esophagitis (2 papers). Luisa Castro-Laria collaborates with scholars based in Spain and France. Luisa Castro-Laria's co-authors include Federico Argüelles‐Arias, Angel Caunedo-Álvarez, Juan Manuel Herrerías‐Gutiérrez, J. Enrique Domínguez‐Muñoz, Manuel Barreiro‐de Acosta, M Rojas-Feria, Valle García-Sánchez, Triana Lobatón, María Chaparro and Francisco Pellicer-Bautista and has published in prestigious journals such as Gastroenterology, Digestive Diseases and Sciences and Inflammatory Bowel Diseases.

In The Last Decade

Luisa Castro-Laria

10 papers receiving 153 citations

Peers

Luisa Castro-Laria

EPIDE

GENET

SURGE

GASTR

DERMA

Rutger Quispel Netherlands

Clotilde Baudry France

Juan E. Naves Spain

E. García‐Planella Spain

Satoshi Motoya Japan

Silvia Nastasio Italy

M Aardoom Netherlands

Kazuhiko Kawakami Japan

Tommy Holmström Sweden

Dat Tran Canada

Rutger Quispel Netherlands

Luisa Castro-Laria

71 ×0.9

EPIDE

60 ×0.8

GENET

80 ×1.6

SURGE

33 ×1.0

GASTR

20 ×0.6

DERMA

Citations per year, relative to Luisa Castro-Laria Luisa Castro-Laria (= 1×) peers Rutger Quispel

Countries citing papers authored by Luisa Castro-Laria

Since Specialization

Citations

This map shows the geographic impact of Luisa Castro-Laria's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luisa Castro-Laria with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luisa Castro-Laria more than expected).

Fields of papers citing papers by Luisa Castro-Laria

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luisa Castro-Laria. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luisa Castro-Laria. The network helps show where Luisa Castro-Laria may publish in the future.

Co-authorship network of co-authors of Luisa Castro-Laria

This figure shows the co-authorship network connecting the top 25 collaborators of Luisa Castro-Laria. A scholar is included among the top collaborators of Luisa Castro-Laria based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luisa Castro-Laria. Luisa Castro-Laria is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Castro-Laria, Luisa, et al.. (2024). High serum levels of ustekinumab are associated with better clinical outcomes during maintenance treatment for inflammatory bowel disease. Therapeutic Advances in Gastroenterology. 17. 1118454956–1118454956. 1 indexed citations

Marín‐Jiménez, Ignacio, Manuel Barreiro‐de Acosta, María Esteve, et al.. (2021). Rapidity of clinical response to adalimumab and improvement of quality of life in luminal Crohn's disease: RAPIDA study. Gastroenterología y Hepatología. 45(3). 165–176. 4 indexed citations

Castro-Laria, Luisa, Angel Caunedo-Álvarez, María-José Montoya-García, et al.. (2018). Does the Antitumor Necrosis Factor-α Therapy Decrease the Vertebral Fractures Occurrence in Inflammatory Bowel Disease?. Journal of Clinical Densitometry. 22(2). 195–202. 14 indexed citations

Castro-Laria, Luisa, Federico Argüelles‐Arias, Valle García-Sánchez, et al.. (2016). Initial experience with golimumab in clinical practice for ulcerative colitis. Revista Española de Enfermedades Digestivas. 108(3). 129–32. 12 indexed citations

Benítez, J M, María Gómez–García, Manuel Castro‐Fernández, et al.. (2015). Prognosis of Patients with Ulcerative Colitis in Sustained Remission After Thiopurines Withdrawal. Inflammatory Bowel Diseases. 21(7). 1564–1571. 22 indexed citations

Caunedo-Álvarez, Angel, Federico Argüelles‐Arias, Luisa Castro-Laria, et al.. (2014). Colon capsule endoscopy is a safe and useful tool to assess disease parameters in patients with ulcerative colitis. European Journal of Gastroenterology & Hepatology. 26(8). 894–901. 22 indexed citations

Castro-Laria, Luisa, et al.. (2014). Sa1086 Adalimumab or Infliximab for the Treatment of Inflammatory Bowel Disease Patients: Which Is More Effective?. Gastroenterology. 146(5). S–196. 1 indexed citations

Argüelles‐Arias, Federico, et al.. (2014). Capsule Endoscopy in the Small Bowel Crohn’s Disease. Gastroenterology Research and Practice. 2014. 1–8. 11 indexed citations

Castro-Laria, Luisa, et al.. (2014). Retroperitoneal hematoma in Crohn's disease patient with warfarin therapy.. PubMed. 106(5). 364–6.

10.

Argüelles‐Arias, Federico, Luisa Castro-Laria, Triana Lobatón, et al.. (2013). Characteristics and Treatment of Pyoderma Gangrenosum in Inflammatory Bowel Disease. Digestive Diseases and Sciences. 58(10). 2949–2954. 48 indexed citations

11.

Argüelles‐Arias, Federico, Luisa Castro-Laria, Manuel Barreiro‐de Acosta, et al.. (2012). Is safety infliximab during pregnancy in patients with inflammatory bowel disease?. Revista Española de Enfermedades Digestivas. 104(2). 59–64. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact